Abstract: A physical unclonable functions (PUF) device including a first copper electrode, a second electrode, and a silicon oxide layer positioned directly between the first copper electrode and the second electrode; a method of producing a PUF device; an array comprising a PUF device; and a method of generating a secure key with a plurality of PUF devices.

Abstract: A method and apparatus for generating information are disclosed. An implementation of the method includes: receiving a target text, the target text including an objective and descriptive information of the objective; performing a dependency syntax parsing on the target text to generate a dependency tree of the target text; matching predetermined syntactic structure tree with the dependency treeto obtain at least one triple, a triple including a subject, a predicate, and an object; and determining, based on words contained in a triple among the at least one triple and a predetermined weight of the syntactic structure tree matched to obtain the triple, a target triple among the at least one triple.

Abstract: A method and an apparatus for event detection, a device, and a storage medium. An event is formed by acquiring a plurality of texts including a target keyword; extracting phrases independently describing event information from titles of the plurality of texts; and clustering the extracted phrases and gathering texts where phrases belonging to a same cluster are located to form an event. The accuracy of the event detection and the recall rate for an event can be improved through the method provided by embodiments of the present application.

Abstract: Embodiments disclosed herein represent powder based additive manufacturing processes which provide a microstructure having improved mechanical properties. The methods may include the use of ultrasonic excitation in combination with the active control of a substrate's temperature to provide some level of control over the microstructure and hence the properties.

Abstract: A pharmaceutical composition is provided having particles of a physical mixture that contain at least one 20-camptothecin or a derivative thereof, at least one surfactant, at least one stabilizer, and at least one diluent. The particles have a mean particle size of less than about 2500 nm. The pharmaceutical composition can be nano- or micro-sized particles containing the 20-camptothecin esters or derivatives thereof as part of a physical mixture, which can provide the active compound in a water-soluble/dispersible, bioavailable form. The particles can be used as an oral pharmaceutical composition which comprises the nano- or micro-sized form of 20-camptothecin esters or derivatives, such as in an oral suspension (e.g., an aqueous suspension), or capsules, or caplets. The pharmaceutical composition can be used in the treatment of a cancer or malignant tumor in a patient by oral administration thereof in a therapeutically effective amount.

Abstract: A pharmaceutical composition is provided having particles of a physical mixture that contain at least one 20-camptothecin or a derivative thereof, at least one surfactant, at least one stabilizer, and at least one diluent. The particles have a mean particle size of less than about 2500 nm. The pharmaceutical composition can be nano- or micro-sized particles containing the 20-camptothecin esters or derivatives thereof as part of a physical mixture, which can provide the active compound in a water-soluble/dispersible, bioavailable form. The particles can be used as an oral pharmaceutical composition which comprises the nano- or micro-sized form of 20-camptothecin esters or derivatives, such as in an oral suspension (e.g., an aqueous suspension), or capsules, or caplets. The pharmaceutical composition can be used in the treatment of a cancer or malignant tumor in a patient by oral administration thereof in a therapeutically effective amount.

Abstract: The present invention provides materials and methods related to culturing stable Treg cells or in vivo expansion of stable Treg cells, the cells made by the methods, treatments for various inflammatory/autoimmune pathologies and transplant/graft rejection, and related materials. Ex vivo induction and expansion of the stable Tregs is described, including use of inducing compositions, such as certain mAbs and other compounds, along with expansion medium comprising IL-2. In vivo expansion of stable Treg cells and treatments for various inflammatory/autoimmune pathologies and transplant/graft rejection are described, including the use of mAbs and their variants.

Abstract: An information searching method and a terminal, which are related to the field of communications technologies, address a problem of operation inconvenience in an information searching process. The method includes displaying, after a user triggers a target letter in an alphabetical index area, information summarized by the target letter in an information display area. The alphabetical index area is used to display an alphabetical index and the information display area is used to display information to be searched for. The method also includes receiving a first specified operation triggered by the user and locking the information displayed in the information display area so that, after the information display area receives a page-turning operation triggered by the user, the information displayed in the information display area is switched only within a range of currently displayed information.

Abstract: A process for making particles for delivery of drug nanoparticles is disclosed herein. The process comprises the steps of (a) forming a suspension of drug nanoparticles by mixing a precipitant solution with an anti-solvent solution under micro-mixing environment, where the formed nanoparticles have a narrow particle size distribution; (b) providing an excipient to at least one of the precipitant solution, the anti-solvent solution and the suspension of drug nanoparticles, the excipient being selected to maintain said drug nanoparticles in a dispersed state when in liquid form; and (c) drying the suspension of drug nanoparticles containing the excipient therein to remove solvent therefrom, wherein removal of the solvent causes the excipient to solidify and thereby form micro-sized matrix particles, each micro-sized particle being comprised of drug nanoparticles dispersed in a solid matrix of the excipient.

Abstract: A method and an apparatus can be used for identifying a posture. The method includes obtaining information about sending an ultrasonic wave by one or more ultrasonic transmitters and obtaining information about receiving the ultrasonic wave by ultrasonic receivers. The one or more ultrasonic transmitters are fixed on an object to be identified. The number of the one or more ultrasonic transmitters is at least one and the number of the ultrasonic receivers is at least three. A posture of the object to be identified can be identified according to the obtained information about sending an ultrasonic wave by one or more ultrasonic transmitters and information about receiving the ultrasonic wave by ultrasonic receivers.

Abstract: A kit for repairing and inflating inflatable items comprises a housing, a compressor assembly housed within the housing, a connecting device having an inlet connected to the compressor assembly and a seat adapted to be fluidically connected to a container assembly for a sealing liquid and to the inlet, a valve configured to be opened automatically when the container assembly is connected to the connection device and elastically maintained in a first position such as to fluidically disconnect the inlet from the seat when the container assembly is disconnected from the connecting device, and a flexible tube fluidically connected to the compressor assembly. In particular, the connecting device comprises an outlet fluidically connected to the valve so as to be fluidically connected to the inlet when the valve is in the first position, and in that the flexible tube is connected to the outlet.

Abstract: The present invention provides materials and methods related to culturing stable Treg cells or in vivo expansion of stable Treg cells, the cells made by the methods, treatments for various inflammatory/autoimmune pathologies and transplant/graft rejection, and related materials. Ex vivo induction and expansion of the stable Tregs is described, including use of inducing compositions, such as certain mAbs and other compounds, along with expansion medium comprising IL-2. In vivo expansion of stable Treg cells and treatments for various inflammatory/autoimmune pathologies and transplant/graft rejection are described, including the use of mAbs and their variants.

Abstract: A kit for repairing and inflating inflatable items comprises a housing, a compressor assembly housed within the housing, a connecting device having an inlet connected to the compressor assembly and a seat adapted to be fluidically connected to a container assembly for a sealing liquid and to the inlet, a valve configured to be opened automatically when the container assembly is connected to the connection device and elastically maintained in a first position such as to fluidically disconnect the inlet from the seat when the container assembly is disconnected from the connecting device, and a flexible tube fluidically connected to the compressor assembly. In particular, the connecting device comprises an outlet fluidically connected to the valve so as to be fluidically connected to the inlet when the valve is in the first position, and in that the flexible tube is connected to the outlet.

Abstract: A process for making particles for delivery of drug nanoparticles is disclosed herein. The process comprises the steps of (a) forming a suspension of drug nanoparticles by mixing a precipitant solution with an anti-solvent solution under micro-mixing environment, where the formed nanoparticles have a narrow particle size distribution; (b) providing an excipient to at least one of the precipitant solution, the anti-solvent solution and the suspension of drug nanoparticles, the excipient being selected to maintain said drug nanoparticles in a dispersed state when in liquid form; and (c) drying the suspension of drug nanoparticles containing the excipient therein to remove solvent therefrom, wherein removal of the solvent causes the excipient to solidify and thereby form micro-sized matrix particles, each micro-sized particle being comprised of drug nanoparticles dispersed in a solid matrix of the excipient.

Abstract: A carbon fiber arrow shaft comprises a hollow tube, a reinforced carbon fiber, and a resinoid binder. The hollow tube has a length between 500-900 mm, an inner diameter between 2-10 mm, and a tube wall thickness between 0.3-2 mm. The reinforced carbon fiber and the resinoid binder form a resin-impregnated carbon fiber. The carbon fiber arrow shaft is formed by directly and continuously winding the resin-impregnated carbon fiber around the hollow tube. The carbon fiber arrow shaft has a head section (L1), a middle section (L2) and a tail section (L3). A winding angle of the carbon fiber at the head section (L1) is changed from a larger winding angle to a smaller winding angle, a winding angle at the middle section (L2) stays constant, and a winding angle at the tail section (L3) is changed from a smaller winding angle to a larger winding angle. The lengths of the head section (L1) and the tail section (L3) are between 25-250 mm.